Meikle S S - OmicsDI

Show results for

Unknown (108)
Proteomics (5)
Transcriptomics (3)
Metabolomics (3)

Organisms

Homo sapiens (4)
Mus musculus (3)
Rattus norvegicus (1)

Repository

pride (5)
biostudies-arrayexpress (3)
MetaboLights (3)

Tissue

Cell culture (2)
Heart (1)
Hepatocyte (1)
Liver (1)
Microglial cell (1)
Neuron (1)
Skeletal muscle (1)

Disease

Alzheimer's disease (1)
Cardiovascular system disease (1)
Human immunodeficiency virus infectious disease (1)

Technology Type

Mass Spectrometry (5)
Shotgun proteomics (4)
Mass spectrometry (3)
Data-independent acquisition (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina HiSeq 2500 (1)
Illumina NovaSeq 6000 (1)
Flow injection analysis MS - (1)
Liquid Chromatography MS - (1)

Publication Date

2025 (3)
2022 (2)
2021 (2)
2020 (1)
2013 (1)
2026 (1)
2023 (1)

CHEBI ID

CHEBI:134451 (3)
CHEBI:137554 (3)
CHEBI:141588 (3)
CHEBI:64423 (3)
CHEBI:64424 (3)
CHEBI:64433 (3)
CHEBI:64567 (3)
CHEBI:71729 (3)
CHEBI:85766 (3)
CHEBI:131439 (2)
CHEBI:132004 (2)
CHEBI:132007 (2)
CHEBI:132590 (2)
CHEBI:132591 (2)
CHEBI:132673 (2)
CHEBI:132676 (2)
CHEBI:133629 (2)
CHEBI:134239 (2)
CHEBI:134241 (2)
CHEBI:134242 (2)
CHEBI:134270 (2)
CHEBI:134271 (2)
CHEBI:134428 (2)
CHEBI:134439 (2)
CHEBI:134460 (2)
CHEBI:134487 (2)
CHEBI:134490 (2)
CHEBI:134587 (2)
CHEBI:136126 (2)
CHEBI:136129 (2)

Metabolite Name

CE 14:0 (2)
CE 16:0 (2)
CE 16:1 (2)
CE 16:2 (2)
CE 17:0 (2)
CE 17:1 (2)
CE 18:0 (2)
CE 18:1 (2)
CE 18:2 (2)
CE 18:3 (2)
CE 20:3 (2)
CE 20:4 (2)
CE 20:5 (2)
CE 22:4 (2)
CE 22:5 (2)
CE 22:6 (2)
LPC 14:0 (2)
LPC 15:0 (2)
LPC 16:0 (2)
LPC 16:1 (2)
LPC 17:0 (2)
LPC 18:0 (2)
LPC 18:1 (2)
LPC 18:2 (2)
LPC 18:3 (2)
LPC 20:1 (2)
LPC 20:2 (2)
LPC 20:3 (2)
LPC 20:4 (2)
LPC 20:5 (2)

Study type

RNA-seq of coding RNA (2)
Transcription profiling by array (1)

Release Date

2025 (15)
2020 (12)
2022 (12)
2024 (11)
2023 (8)
2021 (7)
2019 (6)
2018 (6)
2017 (6)
2014 (5)
2012 (5)
2016 (4)
2015 (4)
2013 (3)
2026 (2)
2009 (2)
2004 (2)
2010 (1)

Lab affiliation

Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA (1)
Baker Heart & Diabetes Inst. (1)
Baker Heart & Diabetes Institute (1)
Department of Biochemistry and Molecular Biology, Lipoproteins and Atherosclerosis Monash University, Australia Baker Heart and Diabetes Institute, Australia (1)
University of Melbourne (1)

Previous page
1 / 12
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 12
Next page

Sort by:

Relevance

Page size

Urinary bacteria in adult women with urgency urinary incontinence.

Not available

S-EPMC4128900 | biostudies-literature

A Global Approach to Dissect Palmitate-induced Impairment of Hepatic Glucose Production

Obesity-induced insulin resistance of the liver is characterised by increased gluconeogenesis, which contributes to elevated blood glucose levels in individuals with type 2 diabetes. Research into how fatty acids induce insulin resistance has commonly focused on the induction of insulin resistance. ...

ORGANISM(S): Rattus norvegicus

2013-11-08 | E-GEOD-52204 | biostudies-arrayexpress

Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT.

Not available

S-EPMC11879676 | biostudies-literature

Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis.

Not available

S-EPMC4648980 | biostudies-literature

SORL1 regulates APOE and CLU levels in human neurons

SORL1 is implicated in the pathogenesis of Alzheimer’s disease (AD) through genetic studies. To interrogate the role(s) of SORL1 in human brain cells, SORL1 null iPSCs are differentiated to neuron, astrocyte, microglial, and endothelial cell fates. Loss of SORL1 leads to alterations in both overlapp...

ORGANISM(S): Homo sapiens (Human)

2023-10-24 | PXD044093 | Pride